383 filings
8-K
PACB
Pacific Biosciences of California Inc
16 Apr 24
PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidance
8:08am
PRE 14A
PACB
Pacific Biosciences of California Inc
Preliminary proxy
15 Apr 24
8:17am
POSASR
PACB
Pacific Biosciences of California Inc
11 Apr 24
Automatic shelf registration (post-effective amendment)
5:02pm
POSASR
PACB
Pacific Biosciences of California Inc
11 Apr 24
Automatic shelf registration (post-effective amendment)
5:02pm
POSASR
PACB
Pacific Biosciences of California Inc
11 Apr 24
Automatic shelf registration (post-effective amendment)
5:00pm
S-8
5w3oh
28 Feb 24
Registration of securities for employees
6:16pm
8-K
7jde1x3ihcpb3p0
15 Feb 24
PacBio Announces Fourth Quarter and Fiscal Year 2023 Financial Results
4:07pm
8-K
228368w
8 Jan 24
PacBio Announces Record Preliminary Fourth Quarter and Full Year Revenue Growing 113% and 56%, respectively
8:03am
8-K
jq6z4 er4u2ikmd
11 Dec 23
Departure of Directors or Certain Officers
8:06am
8-K
wukf81vbak2
30 Oct 23
PacBio Announces Third Quarter 2023 Financial Results
4:06pm
8-K/A
emr2d kiqjvii8
27 Oct 23
Departure of Directors or Certain Officers
5:00pm
D
fbhjiz51em8e8lr
19 Oct 23
$84.76 mm in equity, sold $84.76 mm, 165 investors
4:10pm
8-K
nbxfop56ait1hyo8lv
16 Oct 23
PacBio Announces Appointment of David Meline to Board of Directors
8:08am
S-3ASR
9qxh2ojh 63
3 Oct 23
Automatic shelf registration
4:20pm
8-K/A
0ng951zja
22 Sep 23
Unregistered Sales of Equity Securities
4:05pm
D
s4o1yj epvyg2
17 Aug 23
$85.00 mm in equity, sold $85.00 mm, 47 investors
3:52pm
8-K
1bbyuzoq8z3k7igmdzq
2 Aug 23
PacBio Announces Second Quarter 2023 Financial Results
4:10pm